Gelli D, Vignati E (1976). «Metabolic studies with formebolone (2-formyl-17 (alpha)-methyl-androsta-1,4-diene-11 (alpha), 17 (beta)-diol-3-one) in humans». J. Int. Med. Res.4 (2): 96-105. PMID799985. S2CID86157607. doi:10.1177/030006057600400203.
Felippone F, Resnati G, Scolastico C, Tronconi G (1984). «Synthesis of 2-carboxy-11 beta, 17 beta-dihydroxy-17-methyl-1, 4-androstadien-3-one and related compounds». Steroids43 (3): 271-82. PMID6523544. S2CID54289377. doi:10.1016/0039-128x(84)90045-x.
Dahlberg E, Snochowski M, Gustafsson JA (1981). «Regulation of the androgen and glucocorticoid receptors in rat and mouse skeletal muscle cytosol». Endocrinology108 (4): 1431-40. PMID6970661. doi:10.1210/endo-108-4-1431.
Souness GW, Latif SA, Laurenzo JL, Morris DJ (1995). «11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat». Endocrinology136 (4): 1809-12. PMID7895695. doi:10.1210/endo.136.4.7895695.
Souness GW, Morris DJ (1996). «11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat». Hypertension27 (3 Pt 1): 421-5. PMID8698448. doi:10.1161/01.hyp.27.3.421.
Fürstenberger C, Vuorinen A, Da Cunha T, Kratschmar DV, Saugy M, Schuster D, Odermatt A (2012). «The anabolic androgenic steroid fluoxymesterone inhibits 11β-hydroxysteroid dehydrogenase 2-dependent glucocorticoid inactivation». Toxicol. Sci.126 (2): 353-61. PMID22273746. doi:10.1093/toxsci/kfs022.
nih.gov
ncbi.nlm.nih.gov
Gelli D, Vignati E (1976). «Metabolic studies with formebolone (2-formyl-17 (alpha)-methyl-androsta-1,4-diene-11 (alpha), 17 (beta)-diol-3-one) in humans». J. Int. Med. Res.4 (2): 96-105. PMID799985. S2CID86157607. doi:10.1177/030006057600400203.
Cerutti S, Forlani A, Galimberti E (1976). «Anticatabolic action of formebolone in the castrated rat treated with dexamethasone». Arzneimittelforschung26 (9): 1673-7. PMID1036699.
Felippone F, Resnati G, Scolastico C, Tronconi G (1984). «Synthesis of 2-carboxy-11 beta, 17 beta-dihydroxy-17-methyl-1, 4-androstadien-3-one and related compounds». Steroids43 (3): 271-82. PMID6523544. S2CID54289377. doi:10.1016/0039-128x(84)90045-x.
Dahlberg E, Snochowski M, Gustafsson JA (1981). «Regulation of the androgen and glucocorticoid receptors in rat and mouse skeletal muscle cytosol». Endocrinology108 (4): 1431-40. PMID6970661. doi:10.1210/endo-108-4-1431.
Souness GW, Latif SA, Laurenzo JL, Morris DJ (1995). «11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat». Endocrinology136 (4): 1809-12. PMID7895695. doi:10.1210/endo.136.4.7895695.
Souness GW, Morris DJ (1996). «11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat». Hypertension27 (3 Pt 1): 421-5. PMID8698448. doi:10.1161/01.hyp.27.3.421.
Fürstenberger C, Vuorinen A, Da Cunha T, Kratschmar DV, Saugy M, Schuster D, Odermatt A (2012). «The anabolic androgenic steroid fluoxymesterone inhibits 11β-hydroxysteroid dehydrogenase 2-dependent glucocorticoid inactivation». Toxicol. Sci.126 (2): 353-61. PMID22273746. doi:10.1093/toxsci/kfs022.
semanticscholar.org
api.semanticscholar.org
Gelli D, Vignati E (1976). «Metabolic studies with formebolone (2-formyl-17 (alpha)-methyl-androsta-1,4-diene-11 (alpha), 17 (beta)-diol-3-one) in humans». J. Int. Med. Res.4 (2): 96-105. PMID799985. S2CID86157607. doi:10.1177/030006057600400203.
Felippone F, Resnati G, Scolastico C, Tronconi G (1984). «Synthesis of 2-carboxy-11 beta, 17 beta-dihydroxy-17-methyl-1, 4-androstadien-3-one and related compounds». Steroids43 (3): 271-82. PMID6523544. S2CID54289377. doi:10.1016/0039-128x(84)90045-x.